Primary Clinic (Direct GLP) Review
Best for: Patients in the 10 covered states who want GLP-1 medications as part of a continuous Direct Primary Care relationship (including labs, routine meds, unlimited visits, and ongoing provider monitoring) rather than a transactional DTC marketplace purchase, and who calculate the $89/mo membership fee plus wholesale med cost is favorable vs $300-$500/mo all-in DTC pricing.
Primary Clinic (directglp1.com, also branded as Direct GLP) is a Direct Primary Care (DPC) telehealth membership model — fundamentally different from the DTC GLP-1 marketplace pattern that dominates the rest of the WLR directory. Members pay $89/month for unlimited primary care, direct text access to a provider, same-day virtual visits, routine labs included, and 'thousands of medications' covered. GLP-1 medications are then offered AT WHOLESALE COST to active members with no markup: compounded 503A tirzepatide ranges $110/mo at 2.5mg to $235/mo at 10mg; compounded 503A semaglutide ranges $65/mo at 0.25-0.5mg to $160/mo at 2.7mg. The DPC model means GLP-1 access is bundled with ongoing lab monitoring, medication adjustments, and side-effect management within a continuous primary care relationship. Currently serves 10 states: WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA. Pharmacy partners are described as 'licensed 503A pharmacies' but not named specifically. LegitScript certification is not mentioned. Verbatim disclosure: 'These compounded products are not affiliated with or approved as generic versions of brand-name GLP-1 medications.' Live-verified 2026-05-19 via Chrome MCP (homepage is JavaScript-rendered SPA).
High confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Primary Clinic (Direct GLP) is one of the most affordable GLP-1 options on the market.
Score Breakdown
Drugs Offered
Primary Clinic (Direct GLP) prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| 0.25 mg / 0.5 mg (member wholesale) | compounded | $65 |
| 1 mg (member wholesale) | compounded | $85 |
| 1.7 mg (member wholesale) | compounded | $122 |
| 2.7 mg (member wholesale) | compounded | $160 |
| 2.5 mg (member wholesale) | compounded | $110 |
| 5 mg (member wholesale) | compounded | $160 |
| 7.5 mg (member wholesale) | compounded | $210 |
| 10 mg (member wholesale) | compounded | $235 |
✓ Pros
- •Direct Primary Care (DPC) model integrates GLP-1 with continuous primary care — fundamentally different from DTC marketplace pattern
- •GLP-1 medications at WHOLESALE COST with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- •Unlimited primary care visits + direct text access + same-day care all bundled in $89/mo membership
- •Routine labs and thousands of medications included in membership (no surprise bills)
- •Per-dose pricing transparency for both semaglutide and tirzepatide (all 8 dose tiers listed publicly)
- •Verbatim 503A compounded-medication disclaimer published (no FDA-approval/brand-name confusion)
- •Hybrid model addresses common DTC complaint of 'no continuity of care' for GLP-1 patients
✗ Cons
- •10 states only (WA/NM/AZ/UT/FL/DC/KS/OK/VA/GA) — limited national coverage vs 50-state DTC platforms
- •Membership required to access wholesale GLP-1 pricing — $89/mo adds to year-1 cost (~$1,068/yr fixed)
- •Specific 503A pharmacy partners NOT named
- •LegitScript certification NOT mentioned on the site
- •Named medical director NOT disclosed
- •Corporate legal entity (LLC/Inc/PC) NOT disclosed
- •Brand-name Wegovy/Ozempic/Mounjaro/Zepbound NOT offered — compounded only
- •Site is fully JavaScript-rendered — limited HTML-only crawler visibility
- •Refund policy NOT publicly disclosed
Ready to start with Primary Clinic (Direct GLP)?
Starting at $65/month. See current pricing and start your free consultation.
Sources & methodology
Our Primary Clinic (Direct GLP) review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Primary Clinic (Direct GLP)
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Primary Clinic (Direct GLP)?
Starting at $65/month. See current pricing and start your free consultation.